| Autor: |
Míguez, Héctor Meijide, García, Iñaki Montes, Gómez, Miguel Ochando, Merino, Isabel M. García, Cano, Emilio L., Torre, Alejandro De La |
| Zdroj: |
Revista Española de Geriatría y Gerontología (ScienceDirect); 20230101, Issue: Preprints |
| Abstrakt: |
BNT162b2 (BioNTech and Pfizer) is a nucleoside-modified mRNA vaccine that provides protection against SARS-CoV-2 infection and is generally well tolerated. However, data about its efficacy, immunogenicity and safety in people of old age or with underlying chronic conditions are scarce. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
